CRONOS GROUP INC. Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
CRONOS GROUP INC. (CRON) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of -$2.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-02-26
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-12-31 was $43.94M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was $7.32M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$8.76M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$2.48M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2025 was -$2.93M, a 107.32% decline from fiscal 2024.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2024 was $40.02M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was -$70.44M.
- CRONOS GROUP INC. income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was -$155.18M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | -$2.93M 10-K · filed 2026-02-26 | |||||||
| 2024-12-31 | $43.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $51.27M derived: sum of 2 quarters · filed 2026-02-26 | $42.51M derived: sum of 3 quarters · filed 2026-02-26 | $40.02M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $7.32M 10-Q · filed 2024-11-12 | -$1.44M derived: sum of 2 quarters · filed 2024-11-12 | -$3.92M 10-Q · filed 2024-11-12 | -$49.07M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | -$8.76M 10-Q · filed 2024-08-08 | -$11.24M 10-Q · filed 2024-08-08 | -$56.39M derived: sum of 3 quarters · filed 2026-02-26 | -$57.98M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | -$2.48M 10-Q · filed 2024-05-09 | -$47.63M derived: sum of 2 quarters · filed 2026-02-26 | -$49.23M derived: sum of 3 quarters · filed 2026-02-26 | -$54.89M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | -$45.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$46.74M derived: sum of 2 quarters · filed 2026-02-26 | -$52.40M derived: sum of 3 quarters · filed 2026-02-26 | -$70.44M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | -$1.59M 10-Q · filed 2024-11-12 | -$7.25M derived: sum of 2 quarters · filed 2024-11-12 | -$25.29M 10-Q · filed 2024-11-12 | -$101.47M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | -$5.66M 10-Q · filed 2024-08-08 | -$23.70M 10-Q · filed 2024-08-08 | -$99.88M derived: sum of 3 quarters · filed 2025-02-27 | -$132.98M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | -$18.04M 10-Q · filed 2024-05-09 | -$94.22M derived: sum of 2 quarters · filed 2025-02-27 | -$127.32M derived: sum of 3 quarters · filed 2025-02-27 | -$144.85M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | -$76.18M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$109.29M derived: sum of 2 quarters · filed 2025-02-27 | -$126.81M derived: sum of 3 quarters · filed 2025-02-27 | -$155.18M 10-K · filed 2025-02-27 | -$168.73M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | -$33.10M 10-Q · filed 2023-11-08 | -$36.89M 10-Q · filed 2022-11-07 | -$50.63M derived: sum of 2 quarters · filed 2023-11-08 | -$79.00M 10-Q · filed 2023-11-08 | -$89.88M 10-Q · filed 2022-11-07 | $51.45M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | -$17.53M 10-Q · filed 2023-08-08 | -$20.34M 10-Q · filed 2022-08-09 | -$45.89M 10-Q · filed 2023-08-08 | -$52.99M 10-Q · filed 2022-08-09 | $84.55M derived: sum of 3 quarters · filed 2024-02-29 | $162.14M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | -$32.65M 10-Q · filed 2022-05-10 | $102.08M derived: sum of 2 quarters · filed 2024-02-29 | $179.66M derived: sum of 3 quarters · filed 2024-02-29 | $872.00K derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $134.73M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $212.32M derived: sum of 2 quarters · filed 2024-02-29 | $33.52M derived: sum of 3 quarters · filed 2024-02-29 | -$128.08M 10-K · filed 2024-02-29 | -$396.70M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $77.58M 10-Q · filed 2022-11-07 | -$101.21M derived: sum of 2 quarters · filed 2022-11-07 | -$262.81M 10-Q · filed 2022-11-07 | -$374.39M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | -$178.79M 10-Q · filed 2022-08-09 | $57.34M 10-Q · filed 2021-08-06 | -$340.40M 10-Q · filed 2022-08-09 | -$104.27M 10-Q · filed 2021-08-06 | -$451.98M derived: sum of 3 quarters · filed 2023-02-28 | -$383.04M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | -$161.60M 10-Q · filed 2022-05-10 | -$273.19M derived: sum of 2 quarters · filed 2023-02-28 | -$204.25M derived: sum of 3 quarters · filed 2023-02-28 | -$311.90M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | -$111.58M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$42.64M derived: sum of 2 quarters · filed 2023-02-28 | -$150.30M derived: sum of 3 quarters · filed 2023-02-28 | -$74.62M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $68.94M 10-Q · filed 2022-02-18 | -$38.72M derived: sum of 2 quarters · filed 2022-02-18 | $36.96M 10-Q · filed 2022-02-18 | $98.83M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | -$107.66M 10-Q/A · filed 2022-02-18 | -$31.98M 10-Q/A · filed 2022-02-18 | $29.89M derived: sum of 3 quarters · filed 2022-03-01 | $634.06M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $75.68M 10-Q · filed 2021-05-07 | $137.55M derived: sum of 2 quarters · filed 2022-03-01 | $741.72M derived: sum of 3 quarters · filed 2022-03-01 | |||||
| 2019-12-31 | $61.87M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $666.03M derived: sum of 2 quarters · filed 2022-03-01 | $1.17B 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | $604.16M 10-Q · filed 2020-11-05 | $1.10B 10-Q · filed 2020-11-05 | ||||||
| 2018-12-31 | -$20.92M 10-K · filed 2021-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |